west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "胰岛素" 173 results
  • Risk factors of proliferative diabetic retinopathy in type 2 diabetes

    ObjectiveTo explore the morbidity rate and risk factors of proliferative diabetic retinopathy (PDR) in type 2 diabetes.MethodsThe clinical data of patients, with PDR in 2739 consecutive cases of type 2 diabetes diagnosed in this hospital from 1994 to 2001 were analyed retospectively. The diagnosis of diabetic retinopathy (DR) was confirmed by ophthalmoscopy and fundus fluorescein angiography (FFA). Blood pressure, fasting and postprandial blood sugar, glycosylated haemoglobin(HbA1c), total serum cholesterol, triglyceride, creatinine, and albumin excretion rate were measured.ResultsThe morbidity rate of type 2 DR was 27.8%(761/2739), and the morbidity rate of PDR was 4.2%(114/2 739) occupying 15% of the patients with DR. The duration, fasting blood sugar, glycosylated haemoglobin, blood pressure and albumin excretion rate were much higher than those in the control(P<0.01, glycosylated haemoglobin P<0.05). The independent risk factors of PDR were duration of the disease (r=0.15, P<0.01) and albumin excretion rate (r=0.08, P<0.05). The risk factors of PDR were albumin excretion rate and fasting blood sugar (r=0.13, P<0.05) in patients with longer duration(≥5 years). The morbidity rate of PDR was 2.3%, 5.9% and 12.4% in patients with duration less than 5 years, 5 to 10 years and over 10 years groups, respectively. The morbidity of PDR of the patients in normal albuminuria, microalbuminuria and overt albuminuria group was 2.1%、5.3% and 18.8% respectively.ConclusionsType 2 diabetes accompanied with PDR is relative to the duration of the diabetes, albumin excretion rate, fasting blood sugar, blood pressure, and glycosylated haemoglobin, in which the duration of the disease, albuminuria and fasting blood sugar are the risk factors of occurance of PDR. (Chin J Ocul Fundus Dis, 2003,19:338-340)

    Release date:2016-09-02 06:00 Export PDF Favorites Scan
  • Location Diagnosis and Treatment of Insulinoma (Report of 38 Cases)

    目的 正确评价胰岛素瘤的各种定位诊断方法和各种手术治疗方法。 方法 回顾性分析吉林大学第一医院普外科与吉林省肿瘤医院普外科1985年6月至2005年6月期间诊治的38例胰岛素瘤的临床资料,系统评价术前超声、术中超声、术前CT及术前增强CT定位诊断方法。结果 术前超声、术前CT、术前增强CT及术中超声检查其确诊率分别为47.4%、51.5%、85.7%及100%。行肿瘤局部摘除术21例,单纯远端胰腺切除术14例,远端胰腺切除术联合脾摘除3例。结论 胰岛素瘤的术前定位诊断较困难,术前超声与术前CT在术前定位诊断方面差异无统计学意义,术前增强CT能够明显提高胰岛素瘤的术前诊断率,术中超声是胰岛素瘤最有效的定位诊断方法。行肿瘤摘除术是治疗良性胰岛素瘤的最佳方式,能够降低术后并发症发生率。多发性胰岛素瘤或恶性胰岛素瘤应行胰腺次全切除术以避免复发,必要时可联合脾脏摘除。

    Release date:2016-09-08 11:49 Export PDF Favorites Scan
  • Advances in Research of MicroRNA in The Pathogenesis of Type 2 Diabetes

    Objective To summarize the relationship of diabetes and its complications with microRNA. Methods Domestic and international researches were collected by searching to summarize the role of microRNA in diabetes and its complications. Results MicroRNA could affect the secretion of insulin and interfer metabolism of gulcose in fat cells, muscle cells, and liver cells, which resulting in insulin resistance. At the same time, the microRNA also played an role in damage of vascular endothelial cells and myocardial cell in diabetes. Conclusion MicroRNA acts an important role in the process of diabetes and its complications.

    Release date:2016-09-08 10:35 Export PDF Favorites Scan
  • 2型糖尿病肥胖患者口服降糖药失效启用胰岛素治疗方案的探讨

    【摘要】 目的 探讨2型糖尿病肥胖患者在口服降糖药继发失效的情况下启用胰岛素治疗方案的选择。 方法 选择2009年1月-2010年12月间40例口服降糖药失效的2型糖尿病肥胖患者,随机分为两组,每组20例。A组原口服药不变,睡前联用长效胰岛素(商品名:来得时)治疗,B组停用口服药,于早晚餐前使用预混胰岛素(商品名:诺和灵30R),治疗共3个月,分别于治疗前后观察空腹血糖、餐后2 h血糖、糖化血红蛋白、血脂、血压、体质量指数的变化,记录低血糖发生次数,并填写问卷调查表,评估患者对治疗方案的满意度和接受度。 结果 两个组治疗后空腹血糖、餐后2 h血糖、糖化血红蛋白均较治疗前明显下降(Plt;0.01),而血脂、血压变化不大;但B组体质量指数有轻微升高(Pgt;0.05),且每日胰岛素用量较A组更大(Plt;0.01),低血糖反应更多(Plt;0.05),满意度和接受度不如A组高(Pgt;0.05)。 结论 对2型糖尿病肥胖患者在口服降糖药继发失效的情况下启用胰岛素治疗,选用口服降糖药联合基础胰岛素的治疗方案具有作用佳、安全性好,体重增加不明显,患者依从性更高的特点。【Abstract】 Objective To investigate the selection of insulin therapy for obese patients with type 2 diabetes mellitus (T2DM) after the failure of oral antihyperglycemic drugs. Methods Forty obese T2DM subjects who failed the therapy of oral antihyperglycemic drugs between January 2009 and December 2010 were divided into 2 groups randomly. Patients in group A (n=20) continued using oral antihyperglycemic agents while long-acting insulin (Lantus) was added at bedtime; Patients in group B (n=20) used premixed insulin (Novolin 30R) injection before breakfast and supper instead of the oral drugs. The treatment lasted for 3 months for both groups. Fasting plasma glucose (FPG), blood glucose 2 hours after breakfast (2hPG), glycated hemoglobin (HbA1c), serum lipids, blood pressure, and body mass index (BMI) were examined before and after the trial respectively. We evaluated the satisfaction and acceptance level in all subjects who underwent the treatment with questionnaires. Results FPG, 2hPG, HbA1c after the treatment were significantly lower than those before the treatment in both two groups (Plt;0.01), while serum lipids and blood pressure showed no significant differences. Patients in group B had slightly higher BMI (Pgt;0.05) after the treatment. Compared with patients in group A, they needed a larger insulin dosage (Plt;0.01), had higher hypoglycemia frequency (Plt;0.05) and lower satisfaction and acceptance level (Pgt;0.05). Conclusion For obese patients with T2DM who have failed the therapy of oral antihyperglycemic drugs, combined oral antihyperglycemic drugs with basic insulin has better effects, security, and compliance, and less weight gain.

    Release date:2016-09-08 09:27 Export PDF Favorites Scan
  • The study on light sensitivity in the early central visual field for patients with type Ⅱ diabetes

    Objective To detect the difference of the light sensitivity in the central visual field between normal people and type Ⅱ diabetic patients without diabetic retinopathy, and evaluate the effect of perimetric examination in early diagnosis of diabetic retinopathy. Methods The light sensitivity at the 80 locations in the central field was measured by Dicon field analyzer (model TKS-4000) in 76 normal eyes of 44 normal volunteers aged from 45 to 72 years and 75 eyes of 40 type Ⅱ diabetic patients without retinopathy aged from 46 to 71 years. Results For the diabetic patients without diabetic retinopathy, the light sensitivity of locations decreased by 4-8 dB,and there were some decreased light sensitivity areas. The mean light sensitivity of three zones of the central field had significant reduction in the diabetic patients as compared with the control group(Plt;0.001). Conclusion The retinal neurosensory function of diabetic patients is damaged in some degrees before diabetic retinopathy occured, and no relationship is found between the decrease of retinal light sensitivity and localized blood-retinal barrier leakage. It is suggested that examination of central field with computerized perimetry has certain clinical significance in early diagnosis of diabetic retinopathy. (Chin J Ocul Fundus Dis, 2002, 18: 218-220)

    Release date:2016-09-02 06:01 Export PDF Favorites Scan
  • IMPROVED METHOD FOR OPTIMIZED ISOLATION AND PURIFICATION OF RAT ISLETS AND IDENTIFICATION OF FUNCTION

    【Abstract】 Objective To explore good methods for isolation and purification of rat islets. Methods The isletswere isolated from male SD rat pancreata by a collagenase perfusion method and purified by a modified method: added 4 kinds of Euro-Ficoll of different densities (F1: D=1.132, F2: D=1.108, F4: D=1.069, F5: D=1.023), discontinuous density gradient centrifuge the tube at 2 000 r/min for 20 minutes at 4℃ , then the islets between F1 and F2 were collected. The purity of islets was assessed by dithizone staining with islets counted and scored for size. Islets viabil ity was assessed by fluorescin diacetate / propidium iodide. The function of purified islets was judged by the test of insul in release and islets transplantation. Results After an improved method for optimized isolation and purification, (920±122) IEQ purified islets were obtained from one rat. Both the purity and viabil ity of islets were over 90%. The amount of insul in secretion was (18.25±0.32) mU/L and (36.70±3.57) mU/Lat 2.2 mmol/ L and 22.2 mmol/L concentration of glucose respectively, there was significant difference between the two phases(P lt; 0.05). The insul in release index was 2.01±0.15. Under 1 000 IEQ islets transplantation, the normal glucose level could beremained in diabetic rats. Conclusion High purity and high viabil ity islet cells can be got through improved collagenase perfusion and centrifugation on gradients method.

    Release date:2016-09-01 09:09 Export PDF Favorites Scan
  • The Efficacy and Safety of the Combination of Metformin with Glargine in Type 2 Diabetic Subjects

    摘要:目的:了解甘精胰岛素联合二甲双胍治疗对口服降糖药血糖控制不理想的2型糖尿病患者的疗效和安全性。方法:对30例口服降糖药血糖控制不理想的2型糖尿病患者给与甘精胰岛素联合二甲双胍治疗,共12周。治疗前后测身高、体重、空腹血糖(FPG)、餐后2小时血糖(PPG)以及糖化血红蛋白(HbA1c)水平。了解治疗期间低血糖发生情况。结果:治疗后的FPG、PPG以及HbA1c水平明显下降,分别下降了303mmol/L、510mmol/L和198%,差异有统计学意义(Plt;005)。治疗后5330%的患者HbA1c水平lt;70%。治疗前HbA1c水平≥70%lt;90%的患者,治疗后706%的患者HbA1c水平lt;70%,治疗前HbA1c水平≥90%的患者,治疗后307%的患者HbA1c水平lt;70%,两者的HbA1c达标率有明显差异(Plt;005)。治疗前后体重及BMI无明显差异(Pgt;005)。30例患者中仅发生两次轻微低血糖。结论:甘精胰岛素联合二甲双胍治疗对口服降糖药治疗血糖控制不理想的2型糖尿病患者是安全有效的,尤其是对HbA1c水平lt;90%的患者,血糖控制更好,达标率更高。

    Release date:2016-09-08 09:56 Export PDF Favorites Scan
  • THE DIAGNOSIS AND TREATMENT OF INSULINOMA (REPORT OF 15 CASES)

    Objective To discuss the diagnosis and treatment of insulinoma, clinical characteristics and summarize our experiences. Methods The clinical, operative and pathologic findings from 15 cases of insulinoma of in our hospital from 1989 to 1998 were retrospectively studied. Results All 15 patients recieved surgical treatment. Fourteen patients were cured and the 15th patient died from hepatic failure six months later. Conclusion Insulinoma should be diagnosed and treated as early as possible. It can be cured by resection of the tumor.

    Release date:2016-09-08 02:01 Export PDF Favorites Scan
  • The Risk Analysis of Insulin Injection in Diabetic Patients outside the Hospital by Themselves

    目的 了解糖尿病患者院外自行注射胰岛素存在的风险。 方法 2010年1月-12月,通过随访调查老年组83例,中青年组69例糖尿病患者院外自行注射胰岛素的实施情况,对存在的问题进行归类、统计。调查的内容主要包括3个方面:胰岛素装置的正确使用、胰岛素的规范注射、血糖监测及低血糖处理。分析两组患者院外注射胰岛素的风险,并对存在的问题进行原因分析、提出解决方法。 结果 发放调查表152份,有效回收131份,其中老年组73份,中青年组58份。在胰岛素装置使用方面,老年组存在问题48项,中青年组27项,两者间差异无统计学意义(χ2=2.432,P>0.05)。在胰岛素的规范注射方面,老年组存在问题176项,中青年组77项,老年组在胰岛素注射方面存在的问题明显高于中青年组(χ2=25.009,P<0.001)。在低血糖的认识及正确处理上,老年组存在问题115项,中青年组33项,两组差异具有统计学意义(χ2=40.383,P<0.001)。 结论 糖尿病患者院外自行注射胰岛素存在诸多风险。老年糖尿病患者院外胰岛素注射需在他人协助、监督下进行。

    Release date:2016-09-08 09:13 Export PDF Favorites Scan
  • Biphasic Insulin Aspart 30 Given Three Times Daily for Type 2 Diabetes: A Systematic Review

    Objective To assess the effectiveness and safety of biphasic insulin aspart 30 given three times a day in the management of type 2 diabetes. Methods Such databases as CENTRAL, MEDLINE, PubMed and CNKI were searched on computer; additionally, the relevant conference proceedings from associations like American Diabetes Association, and the references of all selected literatures were also hand-searched. The randomized controlled trials (RCTs) on biphasic insulin aspart 30 given three times a day in treating type 2 diabetes were screened according to inclusive and exclusive criteria, without concerning the limitation of languages and blind methods. After data extraction and quality evaluation, Meta-analysis was performed by using RevMan 4.2 software. Results Ten trials involving 1 415 patients were included. The sub-group analysis showed that compared with the group of given biphasic insulin aspart 30 twice a day (the bid group), the group of given biphasic insulin aspart 30 three times a day (the tid group) was superior in decreasing HbAlc (Plt;0.000 01). Compared with the group of thrice preprandial injection of Novolin R plus one injection of Novolin N at bedtime (the qid group), Meta-analysis showed that, a) As to the average fasting glucose levels: the tid group was not superior to the qid group (P=0.65); b) As to the average 2-hour postprandial glucose levels: the tid group was superior to the qid group (P=0.0003); c) As to the therapeutic time: the tid group was not superior to the qid group (P=0.38); d) As to the insulin doses: the tid group was superior to the qid group (P=0.000 1); e) As to the insulin costs: the tid group was inferior to the qid group (P=0.02); and e) As to the incidence of hypoglycaemia: the tid group was superior to the qid group (P=0.000 2). Compared with the oral antidiabetic drugs, the results of Meta-analyses showed: the tid group was superior in decreasing HbAlc (P=0.001). Conclusion The limited current evidence shows that biphasic insulin aspart 30 given three times a day, as a simple insulin intensified scheme, is safe and effective for type 2 diabetes, and is worth recommending in clinic. However, all these findings should be further confirmed with more large sample and well-designed RCTs.

    Release date:2016-09-07 11:00 Export PDF Favorites Scan
18 pages Previous 1 2 3 ... 18 Next

Format

Content